StageZero Life Sciences Ltd T.SZLS

The next week will be monumental.

[SAGDollar]

It's make of break time. We all have dug dirt to the inner mantel. We have sent countless emails to IR. We have spent a few tough years here. Let's hope the previous frustration pays off and we can start to see this take flight. My excitement for Friday is through the roof... I could see them possibly blind siding us with Q2 financials before Friday just as a middle finger to penny flippers and day traders that have manipulated this in to the ground many times. I expect to see lots of 001 bids come Monday and this to rally up prior to release... But thats just my speculation.

[Mermer2328]

calm down, you did this last time remember.. although I love the enthusiasm, q2 being monumental is quite the overstatement. q3, different ballgame!!

[Thisguyiscool]

Agreed!!! I expect a dip after q4's and a huge ramp up at q4's Glta

[Thisguyiscool]

Sorry, dip after Q2s and ramp up at Q3s Fat fingers

[SAGDollar]

I'm not expecting massive revenue. Allow me to clarify what I mean by monumental. I mean anything north of 500K is monumental in the fact that it will show a prelude of whats to come in Q3 and reinforce their punctuality of the prosectous. I will take full ownership and apologize for my overally high expectations last Q and over analyzing JHTs "bolus of revenue" statement. How ever I

[Mermer2328]

Trust me SAG, I'm on you're side. and hope this will turn the tide, I've gotta good feeling . to not have shared before q3 numbers is mind boggling to me. Good luck man

[SAGDollar]

Haha were all on the same side here amigo. Except for Tina ;). It would be nice to see a touch of revenue Friday from Q2. Then them mention July testing numbers the following Monday in the AGM. Maybe I'm hoping for too much. Regardless il be happy to see this back over 10 cents soon.

[capebretongirl]

Yes, we need revenue numbers from Q2 to be decent - they don't have to be outstanding. If Q2 is reasonable then it will be a given that Q3 will be strong.  The wildcard here is that the US will eventually clean up its covid act and testing requirements will decrease. SZ will then have less and less covid testing revenue - so ultimately it will be up to the likes of colonsentry and

[Bucky86]

Well said CBG. I agree. Covid testing is a temporary phase in this company's evolution. That being said if Q2 #s are bad...ie show no real significant* uptick I'd be skeptical that Q3 will be outstanding either. My point is we always look ahead to the next Q and the next Q etc. If I'm not wowed by June #s in particular I'll predict an average Q3 also.... Just my opinion. The time

[Northerencents]

Yep time to show us the money plain and simple....as SAG said even a million in revenue would be quite monumental considering this is only a third of the quarter in a new testing world

[LithLover]

Keep in mind the 4 million in recent offering was to cover costs for the next year and the plan for Aristotle commercialization. Even if no revenues from covid.  In the recent panel discussion last week he still confirmed roll out by end of year.  So covid revenues can be minimal and plan is still moving forward.  12 new hires would suggest covid testing is booming but all that is

[SAGDollar]

I think Mercer will be a teriffic partner to market Aristotle to previous companies that szls has offered covid tests to. Was Mercer the large healthcare provider that had a previous NDA? Or is there still another wild card hidden in the deck?

[RelevantStock]

Ah yeah definitely the best. Aristotle will benefit the most to the employers that offer insurance plans to a large pool of workers, allowig them to save huge costs on cancer treatments (in USA). I am here mostly for covid revenue for the moment though, as much as I like Aristotle and believe in its future. Glad they are working on following the prospectus plan, I have them in high respect for

[RelevantStock]

For those wondering the new lab techs hires are mostly for covid and not Aristotle I believe. There is no time emergency on delivering a cancer test result. Covid results are time critical and they need a more important workforce. Tripp has said in the last interview we were kinda Mercer's favorite choice for covid testing small companies, fast results are critical for this.

[LithLover]

Well that would suck to keep bringing in millions per quarter until we roll out Aristotle    Not lol.

[LithLover]

Think of the value instead of 10 separate  tests at $200-400 each a simple single test for 10 cancers single priced utilizing the covid and telehealth partners. Millions in covid revenue and than roll right into Aristotle using the same logistics.   Let's go  

[RelevantStock]

I was wondering the price of an Aristotle test, I was thinking more like 750$ US... everything is there Lith... You guys do amazing DD, the telehealth network, Mercer, the clia lab, covid, stagezero upcoming web platform... I just need to see $$$ on paper. Many times reality defies logical expectations in business and we cannot count on szls to have true insights on the progress. I understand they

[RelevantStock]

they hired many new lab techs, we are trusted by Mercer for covid, we have new lab equipment, it's very fair to except a major boost in revenue. Tripp has also said forget everything about 2019 and before this is a different game, and I believe him.

[RelevantStock]

yeah colonsentry is 375$ us so I expect Aristotle to be a little more than 2x the price.

[valentinemasson]

He basically put his reputation on the line with those statements. Past has passed, hopefully he has morphed into a Man of his word. This is a Rep game changer, and if it rings true, the entire landscape of this company will be on track building a solid foundation leading up to the new partnerships and a successful launch of Aristotle. Good luck everyone. VM.

[covidstocks78]

This post has been removed in accordance with Community Policy

[covidstocks78]

This post has been removed in accordance with Community Policy

[Oilminerdeluxe]

Maybe it has been written before, but how many  test can one person do per day? If they have x number of those lab testers employed, it would be easier to figure how much is being done per day.

[Liked2Think]

Yike the word monumental.  That word scares me when it comes to this stock. I to have been waiting for Q2 and putting that word monumental out there will give me nightmares of previous vanishing $30M talk. At this point with what is going on the "monumental" thing we need is some revenue.  Not an absolute ton but some but the bigger thing is a true update on what they have

[SAGDollar]

Would this share price not light up like MIR or Sona if SZ could finally verify their revenue stream from this covid situation? I think any revenue of substance is monumental considering this comapny has been in the red for two decades. Is there a better word than monumental to sum up what this revenue would be? I don't want to be unrealistic or over hyped as I have before. The thought of last

[Thor6570]

Interesting all this talk of 2 quarter revenue and results. I invested here for the promised cancer detection products. Covid is a bonus for us and hopefully we can take advantage. I hope recent job posts are an indication that sales are indeed ramping up with covid testing. So for me the real results will not be meaningful until 2 quarter results next year.

[PlumpGrumpTrump]

This post has been removed in accordance with Community Policy